Invention Grant
- Patent Title: Cell penetrating peptide inhibitors of p53-MDM2 interaction
-
Application No.: US15880101Application Date: 2018-01-25
-
Publication No.: US10583193B2Publication Date: 2020-03-10
- Inventor: Yanwen Fu , Gunnar F. Kaufmann
- Applicant: Sorrento Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: Sorrento Therapeutics, Inc.
- Current Assignee: Sorrento Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: McNeill Baur PLLC
- Main IPC: A61K47/54
- IPC: A61K47/54 ; C07K19/00 ; A61P35/00 ; A61K38/10 ; C07K9/00 ; A61K47/64
Abstract:
Provided are compounds having the Formula I or II: and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and their use in the treatment of cancers.
Public/Granted literature
- US20180207285A1 CELL PENETRATING PEPTIDE INHIBITORS OF p53-MDM2 INTERACTION Public/Granted day:2018-07-26
Information query
